Abstract
Celecoxib (CXB) is a poorly aqueous solubility sulfonamide non-steroidal anti-inflammatory drug (NSAID). Hence, the formulation of CXB was selected for solubilization and bioavailability. To find out suitable formulation for microemulsion, the solubility of CXB in triacetin (oil phase), Tween 80 (surfactant), and Transcutol-P (co-surfactant) was screened respectively and optimized by using orthogonal experimental design. The Km value and concentration of oil, Smix, and water were confirmed by pseudo-ternary phase diagram studies and central composite design. One percent carbopol 934 was added to form CXB microemulsion-based gel. The final formulation was evaluated for its appearance, pH, viscosity, stability, drug content determination, globule size, and zeta potential. Its ex vivo drug permeation and the in vivo pharmacokinetic was investigated. Further research was performed to ensure the safety and validity by skin irritation study and in vivo anti-inflammatory activity study. Ex vivo permeation study in mice was designed to compare permeation and transdermal ability between microemulsion formulation and conventional gel. The results revealed that optimized microemulsion-based gel gained higher permeation based on smaller globule size and high drug loading of microemulsion. Transdermal ability was also greatly improved. Bioavailability was compared to market Celebrex® by the in vivo pharmacokinetic study in rabbits. The results indicated that CXB microemulsion-based gel had better bioavailability than Celebrex®.
Similar content being viewed by others
References
Frampton JE, Keating GM. Celecoxib: a review of its use in the management of arthritis and acute pain. [J]. Drugs. 2007;67(16):2433–72.
Crofford LJ, Tan B, Mccarthy CJ, et al. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. [J]. Arthritis Rheumatol. 1997;40(2):226–36.
Cho JG, Lee ES, Woo JS, et al. Expressions of cyclooxygenase 1 and 2 in endotoxin-induced otitis media with effusion in the rat [J]. Int J Pediatr Otorhinolaryngol. 2007;71(1):101–6.
Seo KW, Coh YR, Rebhun RB, et al. Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines [J]. Res Vet Sci. 2014;96(3):482–6.
Trifan OC, Durham WF, Salazar VS, et al. Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11 [J]. Cancer Res. 2002;62(20):5778–84.
Danielsson I, Lindman B. The definition of microemulsion [J]. Colloids Surf. 1981;3(4):391–2.
Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy ☆[J]. Adv Drug Deliv Rev. 2012;64(11):206–12.
Kumar S, Burgess DJ. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions [J]. Int J Pharm. 2014;466(1–2):223–32.
Saupe A, Rades T. Solid lipid nanoparticles [J]. Adv Drug Deliv Rev. 2012;64(3):83–101.
Tongcumpou C, Acosta EJ, Quencer LB, et al. Microemulsion formation and detergency with oily soils: I. Phase behavior and interfacial tension [J]. J Surfactants Deterg. 2003;6(3):191–203.
De M, Bhattacharya SC, Panda AK, et al. Interfacial behavior, structure, and thermodynamics of water in oil microemulsion formation in relation to the variation of surfactant head group and cosurfactant [J]. J Dispers Sci Technol. 2009;30(30):1262–72.
Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. [J]. Adv Drug Deliv Rev. 2000;45(1):89–121.
Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles [J]. Adv Colloid Interf Sci. 2006;123–126(21):369–85.
Kong M, Chen XG, Dong KK, et al. Investigations on skin permeation of hyaluronic acid based nanoemulsion as transdermal carrier [J]. Carbohydr Polym. 2011;86(2):837–43.
Peira E, Scolari P, Gasco MR. Transdermal permeation of apomorphine through hairless mouse skin from microemulsions [J]. Int J Pharm. 2001;226(1–2):47–51.
Patel HK, Barot BS, Parejiya PB. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies. [J]. Colloids Surf B Biointerfaces. 2013;102(102):86–94.
Hirano S, Kondo S, Ohe Y. Chitosan gel: a novel polysaccharide gel [J]. Polymer. 1975;16(8):622.
El-Kattan AF, Asbill CS, Michniak BB. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems [J]. Int J Pharm. 2000;198(2):179–89.
Ord GN, Percus JK. Development of polyvinyl alcohol-sodium alginate gel-matrix-based wound dressing system containing nitrofurazone. [J]. Int J Pharm. 2008;359(1–2):79–86.
Gupta G, Gaud R. Antiinflammatory activity of tenoxicam gel on carrageenan-induced paw oedema in rats [J]. Indian J Pharm Sci. 2006;68(3):356.
Liu W, Hu M, Liu W, et al. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate [J]. Int J Pharm. 2008;364(1):135–41.
Dargahi M, Kazemian H, Soltanieh M, et al. High temperature synthesis of SAPO-34: applying an L9 Taguchi orthogonal design to investigate the effects of experimental parameters [J]. Powder Technol. 2012;217(2):223–30.
Pan G, Jia X, Pan G, et al. Comparison among several preparation methods for pseudo-ternary phase diagrams of pharmaceutical microemulsions [J]. Chin Pharm. 2006.
El-Badry M, Fetih G. Preparation, characterization and anti-inflammatory activity of celecoxib chitosan gel formulations [J]. J Drug Delivery Sci Technol. 2011;21(2):201–6.
Shakeel F, Baboota S, Ahuja A, et al. Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment. [J]. J Drug Target. 2008;16(10):733–40.
Nikumbh KV, Sevankar SG, Patil MP. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen. [J]. Drug Deliv. 2013;22(4):509–15.
Aboofazeli R, Lawrence MJ. Investigations into the formation and characterization of phospholipid microemulsions. I. Pseudo-ternary phase diagrams of systems containing water-lecithin-alcohol-isopropyl myristate [J]. Int J Pharm. 1993;69(69):1107–10.
Aboofazeli R, Lawrenc CB, Wicksb SR, et al. Investigations into the formation and characterization of phospholipid microemulsions. III. Pseudo-ternary phase diagrams of systems containing water-lecithin-isopropyl myristate and either an alkanoic, acid, amine, alkanediol, polyethylene glycol alkyl et [J]. Int J Pharm. 1994;111(1):63–72.
Rao S, Barot T, Rajesh K S, et al. Formulation, optimization and evaluation of microemulsion based gel of butenafine hydrochloride for topical delivery by using simplex lattice mixture design[M]// Proceedings of the IEEE Signal Processing Workshop on Higher-Order Statistics, June 14–16, 1999, Caesarea, Israel/. :1x–12.
Kumar R, Kumar S, Sinha VR. Evaluation and optimization of water-in-oil microemulsion using ternary phase diagram and central composite design [J]. J Dispers Sci Technol. 2015;37(2):166–72.
Bachhav YG, Patravale VB. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation [J]. Int J Pharm. 2009;365(2):175–9.
Tao W, Xu T, Pan J, et al. Microemulsion based gel for topical dermal delivery of pseudolaric acid B: in vitro, and in vivo, evaluation [J]. Int J Pharm. 2015;493(1–2):111–20.
Mandal S, Das S. Design and development of carbamazepine mucoadhesive microemulsion for intranasal delivery: an ex vivo study [J]. Int J Pharm Sci Rev Res. 2010;3(1):56–60.
Shahin M, Hady SA, Hammad M, et al. Optimized formulation for topical administration of clotrimazole using pemulen polymeric emulsifier. [J]. Drug Dev Ind Pharm. 2010;37(5):559–68.
Miao Y, Sun J, Chen G, et al. Enhanced oral bioavailability of lurasidone by self-nanoemulsifying drug delivery system in fasted state [J]. Drug Dev Ind Pharm. 2015;1–22.
Acknowledgements
The authors are thankful to Jiangsu ChiaTai QingJiang Pharmaceutical Co. Ltd., for generously providing the gift sample of CXB. The authors also thank the Jiangsu Institute of Pharmacy, School of Pharmaceutical Sciences, Nanjing Tech University, for providing the necessary facilities.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The in vivo pharmacokinetic study of CXB microemulsion-based gel was implemented on the basis of the “Principles of Laboratory Animal Care” and was permitted by the Nanjing Medical University Institutional Animal.
Rights and permissions
About this article
Cite this article
Cao, M., Ren, L. & Chen, G. Formulation Optimization and Ex Vivo and In Vivo Evaluation of Celecoxib Microemulsion-Based Gel for Transdermal Delivery. AAPS PharmSciTech 18, 1960–1971 (2017). https://doi.org/10.1208/s12249-016-0667-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-016-0667-z